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Enhancement of CD8 T-cell function through modifying surface
glycoproteins in young and old mice
Introduction
The immune system undergoes substantial change with
age in both humans and animals. These changes are com-
plex in nature and can include alterations in both the
strength and quality of the immune response.1 Studies of
the adaptive response have suggested age-dependent alter-
ations in the generative, selective, homeostatic, and sig-
nal-transducing elements of the system.2–5 The most
consistent and dramatic of these effects are on the T-cell
compartment. CD4 T-cell responses of aged donors are
typically slower and of lower amplitude than those of
their young counterparts. A decline in the induction of
the Ca2+ response,6 activation of protein kinase pathway,7
production of cytokines and induced cytokine receptors,8
and activation of the genes necessary for cell cycle entry9
are all well documented. Recent findings from our labor-
atory suggest that many of the shortcomings in CD4
T-cell activation might be caused by defects in cyto-
skeletal reorganization that precede the discrimination of
agonist from antagonist peptides by the T-cell receptor
(TCR)10 in conjunction with alterations in T-cell surface
glycosylation patterns.11
T-cell development and differentiation are accompan-
ied by changes in cell surface N- and O-linked glycans,
as well as by alterations in glycoprotein sialylation.12
These changes might regulate the T-cell response through
a direct effect on the intrinsic properties of specific pro-
teins, or by modulating the binding of a disparate set of
cell surface proteins to a specific carbohydrate moiety.
Specific proteases and glycosidases serve as an important
tool in studying the structural and functional charac-
teristics of cell surface glycoproteins. In recent work, our
laboratory has made use of two enzymes in particular:
a sialidase from Clostridium perfringens (CP-Siase)13 and
the O-sialoglycoprotein endopeptidase (OSGE) from
Pasteurella haemolytica.14 CP-Siase cleaves terminal sialic
acids linked via an a(2,3), a(2,6) or a(2,8) binding to
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Summary
Previous work from our laboratory has shown that modifying cell sur-
face glycosylation with either a Clostridium perfringens-derived sialidase
(CP-Siase), or an O-linked glycoprotein endopeptidase (OSGE) can
enhance the function of CD4 T cells from both young and old mice at
multiple levels. Here we have re-assessed the effect of age on CD8 T-cell
function, and examined the outcome of enzymatic treatment with
CP-Siase and OSGE on its different aspects. Pre-treatment of CD8 T cells
with either CP-Siase or OSGE led to a significant increase in anti-CD3-
mediated Ca2+ response in both young and old mice. Pre-treated CD8 T
cells from both age groups also displayed a significant increase in activa-
tion-induced CD69 and CD25 expression, and produced significantly
higher amounts of interleukin-2 and interferon-c in comparison to their
untreated counterparts. Furthermore, pretreatment with either enzyme
enhanced granzyme B expression in CD8 T cells, and increased their cyto-
lytic activity in vitro. These data support the notion that glycosylated sur-
face proteins hinder CD8 T-cell activation and function in both young
and old mice, and raise the possibility of significantly improving CD8 T
cell function in older individuals through enzymatic alteration of surface
glycoproteins.
Keywords: rodent; ageing; TCR; signal transduction; glycosylation
Abbreviations: CP-Siase, Clostridium perfringens-derived sialidase; OSGE, O-sialoglycoprotein endopeptidase.
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N- or O-glycosidic-bound oligosaccharide chains of glyco-
proteins.15 On the T-cell surface, terminal sialic acid resi-
dues predominantly bind to galactose through a(2,3) and
less frequently through a(2,6) links. A number of labor-
atories have documented the importance of the a(2,3)
bond in CD8 T-cell homeostasis and in CD8–major his-
tocompatibility complex (MHC) class I interactions16,17
and that of a(2,6) in CD45 clustering, phosphatase
modulation and T-cell death.18 OSGE is a neutral metal-
loprotease that cleaves the protein backbone of O-glyco-
sylated proteins on serine and threonine residues.14
CD34, CD43, CD44 and CD45 are proven targets of this
enzyme.
We have recently shown that treatment of CD4 T cells
with either CP-Siase or OSGE can enhance multiple
aspects of CD4 T-cell function, leading to similar levels of
function in young and old mice.11,19,20 More specifically,
treatment of CD4 T cells from aged mice with OSGE can
restore early agonist-independent and subsequent agonist-
dependent stages of synapse formation. Furthermore, pre-
treatment with either CP-Siase or OSGE enhances the
CD3-mediated Ca2+ response in CD4 T cells and their
subsets; increases the induced expression of the early acti-
vation markers CD69 and CD25; and heightens the CD3/
CD28-mediated production of interleukin-2 (IL-2) and
interferon-c (IFN-c) in both age groups.
In an effort to extend our previous findings, in the pre-
sent study we have examined the effects of CP-Siase and
OSGE on CD8 T-cell function in young and old mice.
Materials and methods
Mice
Specific pathogen-free male C57BL/6 J and (BALB/cJ ·
C57BL/6 J) F1 (CB6F1) mice were purchased from the
National Institute of Aging contract colonies. The mice
were considered young at 4–8 months of age, and old at
18–24 months of age. They were kept under specific
pathogen-free (SPF) conditions at the University of Mich-
igan Medical School Animal facilities, and given free
access to food and water. Sentinel animals were examined
quarterly for serological evidence of viral infection. All
such tests were negative during the course of these stud-
ies. Mice with splenomegaly or macroscopically visible
tumours at the time of sacrifice were not used in these
experiments.
Antibodies, cell line and reagents
Antibodies against CD3 (clone 145–2C11), CD4 (clone
GK1.5), CD8a (clone 53-6.7), CD19 (clone 1D3), CD25
(clone 7D4), CD28 (clone 37.51), CD44 (clone IM7),
CD69 (clone H1.2F3), Fc RIII/II (clone 2.4G2), immuno-
globulin M (IgM; clone R6-60.2), as well as Cytofix/Cyto-
perm, and Perm/Wash buffers were obtained from BD
Biosciences (San Diego, CA). Anti-granzyme B (clone
16G6) was from eBioscience (San Diego, CA). P815, a
DBA/2-derived (H-2d) mast cell line, was bought from
the American Type Culture Collection (Manassas, VA).
Indo-1 AM was from Molecular Probes (Eugene, OR).
IL-2 and IFN-c enzyme-linked immunosorbent assay
(ELISA) kits, and recombinant mouse IL-2 were pur-
chased from BioSource International (Camarillo, CA).
CP-Siase and OSGE were from Roche (Indianapolis, IN),
and CedarLane (Hornby, Ontario, Canada), respectively.
51Cr (specific activity >200 Ci/g Cr) was acquired from
MP Biomedicals (Irvine, CA).
Enzyme treatment
Cells (5 · 106/ml in Hanks’ balanced salt solution
(HBSS)) were treated with either CP-Siase (100 mU/ml)
or OSGE (50 lg/ml) for 60 min at 37, and then washed
with HBSS to remove the enzyme prior to the use of cells
in any experiment. Control cells were similarly incubated
in HBSS but without added enzyme.
Measurement of cytosolic Ca2+
Cytosolic Ca2+ measurement was performed as previously
described.20 Cells were loaded with Indo-1 AM (25 lM)
at room temperature for 30 min, washed and then stained
with anti-CD8 and anti-CD44 antibodies. The Ca2+
mobilization assay was conducted at 37 on a FACSV-
antage flow-cytometer using FACSDiva software (BD Bio-
sciences, San Jose, CA). Baseline levels were collected for
20 s, after which the cells were stimulated with 5 lg/ml
of non-cross-linked anti-CD3. Each assay was performed
for a 5 min period. The acquired data were analysed
using FlowJo’s kinetic platform (TreeStar, Ashland, OR).
Each histogram displays the mean of the violet : blue
ratio as a function of time with smoothing for moving
average.
Measurement of cytokine levels
Splenic T cells were purified as previously described.21
Purified T cells were labelled with anti-CD4 antibody at
4 for 30 min, washed and then incubated with anti-rat
IgG-coated magnetic beads to obtain CD8 T cells through
negative selection. The CD8 T cells (either untreated or
pretreated with CP-Siase or OSGE) were stimulated with
1 lg/ml each of non-cross-linked anti-CD3 and anti-
CD28 for 6 hr in complete RPMI-1640 at 37 in a 5%
CO2 atmosphere. The supernatants were collected at the
end of the stimulation period, and stored at )70 until
further analysis. For each sample, IL-2 and IFN-c levels
were quantified using ELISA kits according to the manu-
facturer’s instructions. The detection limits of the kits
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were 8 pg/ml for IL-2, and 1 pg/ml for IFN-c,
respectively.
Induction and measurement of cytotoxic T lymphocyte
(CTL) activity
Induction and measurement of cytotoxic activity were
carried out as previously described22 with certain modifi-
cations. Splenocytes from young CB6F1 mice (H-2b,d)
were used as stimulators after exposure to 2000 rads of
c-irradiation, whereas splenocytes from young and old
C57BL/6 mice (H-2b) were used as responders. The sti-
mulator and responder cells were coincubated for 7 days.
The harvested cells were labelled with anti-CD4, anti-
CD19 and anti-IgM antibodies at 4 for 30 min, washed
and then incubated with anti-rat IgG-coated magnetic
beads to obtain CD8 T cells through negative selection.
The CD8 T cells were either left untreated as controls, or
exposed to CP-Siase or OSGE. Afterwards, untreated and
enzyme-treated CD8 T cells from individual young and
old responders were incubated in triplicate wells with
5 · 103 51Cr-labelled P815 (H-2d) target cells for 4 hr at
effector to target ratios of 30 : 1, 10 : 1, 3 : 1, and 1 : 1.
To determine spontaneous and maximal 51Cr release from
the targets, the P815 cells were incubated with complete
RPMI-1640 alone or with complete medium containing
1% sodium dodecyl sulphate, respectively. At the end of
the incubation period, the supernatants were harvested
and counted on a c counter. The corrected percent lysis
for each concentration of effector cells was calculated,
using the mean c.p.m. for each replicate of wells:
corrected percentage lysis ¼ 100 · (sample 51Cr release )
spontaneous 51Cr release)/(maximal 51Cr release ) spon-
taneous 51Cr release).
Detection of granzyme B
Splenic T cells (either untreated or pretreated with
CP-Siase or OSGE) were either stimulated with cross-
linked anti-CD3 (5 lg/ml) and anti-CD28 (2 lg/ml) for
6 hr, or cultured with 100 IU of recombinant IL-2 for
72 hr, in complete RPMI-1640 at 37 in a 5% CO2
atmosphere. Intracellular staining was conducted as
previously described.23 Briefly, at the end of each
period, the collected T cells were washed, preblocked
with anti-Fc RIII/II for 5 min, and then labelled with
anti-CD44 and anti-CD8 antibodies. Afterwards, the
cells were fixed overnight in Cytofix/Cytoperm buffer,
washed with Perm/Wash buffer, and then labelled with
anti-granzyme B antibody.
Statistical analyses
In the case of Ca2+ assays, the peak increase above base-
line was calculated for CD8 T cells and their subsets in
every sample, with the data then analysed using Friedman
ANOVA. Post-hoc analysis was done using Wilcoxon
matched pairs tests. In all other cases, the data were ana-
lysed using repeated measures ANOVA. Post-hoc analyses
were done using paired t-tests.
Results
Pre-treatment of CD8 T cells with either CP-Siase
or OSGE leads to enhanced anti-CD3-mediated
Ca2+ response
We have previously shown that both CP-Siase19 and
OSGE20 can enhance the anti-CD3-induced Ca2+ response
in CD4 T cells of both young and old mice. In this study,
we examined the effect of the enzymes on CD8 T cells
and their subsets. Figure 1(a) shows the outcome of one
of eight experiments conducted, where anti-CD3 is used
to induce a transient increase in cytosolic Ca2+. In the
absence of enzyme treatment, the CD8 T-cell response
was significantly higher in the young than in the old
(P ¼ 002). Naive CD8 T cells (CD8 CD44lo) in each age
group had a significantly higher response to anti-CD3 sti-
mulation than their memory (CD8 CD44hi) counterparts
(P ¼ 0007 for both young and old). Ageing had a signifi-
cant effect on the Ca2+ response of the memory CD8 T
cells (P ¼ 002), but not on the naive CD8 T-cell sub-
set (P ¼ 038). Pre-treatment with either CP-Siase or
OSGE significantly enhanced the anti-CD3-induced Ca2+
response in CD8 T cells from both young and old mice.
This was true for CD8 T cells as a whole, as well as for
their naive and memory subsets (P ¼ 0007 for each
comparison; Fig. 1b).
Pre-treatment of CD8 T cells with either CP-Siase
or OSGE increases the anti-CD3/CD28-induced
expression of CD69 and CD25
T cells from young and old mice were either left untrea-
ted or were treated with CP-Siase or OSGE, and then
stimulated with non-cross-linked anti-CD3 (05 lg/ml)
and anti-CD28 (05 lg/ml) antibodies. CD69 and CD25
expression levels on CD8 T cells were examined after 6
and 24 hr of stimulation, respectively (Fig. 2). In the
absence of enzyme treatment, CD8 T cells from young
and old mice showed no significant difference in the
induced expression of CD69 (P ¼ 014) or CD25 (P ¼
014). Pre-treatment of the CD8 T cells with CP-Siase led
to an increase in the induced expression of CD69 and
CD25 in both young (CD69: P ¼ 0004; CD25: P ¼ 003)
and old (CD69: P ¼ 00001; CD25: P ¼ 0002) mice.
Pre-treatment with OSGE also augmented the induced
expression of the two markers in both young (CD69:
P ¼ 00001; CD25: P ¼ 00006) and old (CD69: P ¼
00001; CD25: P ¼ 0008) age groups. Neither CP-Siase
 2006 Blackwell Publishing Ltd, Immunology, 119, 187–194 189
Enzymatic enhancement of CD8 T-cell function
nor OSGE induced the expression of CD69 or CD25 in
the absence of anti-CD3/CD28 stimulation (data not
shown).
Pre-treatment of CD8 T cells with either CP-Siase
or OSGE causes higher production of IL-2 and IFN-c
after anti-CD3/CD28 stimulation
To study the effect of enzyme treatment on cytokine
secretion by CD8 T cells, CD8 T cells (either untreated or
pretreated with CP-Siase or OSGE) were stimulated with
non-cross-linked anti-CD3 and anti-CD28 for 6 hr. The
concentrations of IL-2 and IFN-c in each supernatant
were then determined by ELISA (Fig. 3). Untreated CD8
T cells from young and old mice secreted similar amounts
of IL-2 (P ¼ 04) after anti-CD3/CD28 activation. In con-
trast, CD8 T cells from old mice produced significantly
higher amounts of IFN-c than their young counterparts
(P ¼ 005). Pre-treatment of the cells with CP-Siase
caused an increased secretion of both cytokines in young
(IL-2: P ¼ 0007; IFN-c: P ¼ 001) and old (IL-2: P ¼
001; IFN-c: P ¼ 0006) mice. Pre-treatment with OSGE
also augmented the production of both cytokines in the
young (IL-2: P ¼ 003; IFN-c: P ¼ 001) and old (IL-2:
P ¼ 0001; IFN-c: P ¼ 0009) age groups.
Both CP-Siase and OSGE pretreatment enhance
CD8 T-cell mediated cytotoxicity
The influence of ageing on the generation of cytotoxic T
cells in vitro is a matter of contention. Assays performed
with bulk splenic cultures have led to reports of either an
increase or a decrease in cytotoxic activity with age.24,25
Fractionation studies have shown that any decline with
age is at least partly due to the lack of adequate T-cell
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Figure 1. Effects of CP-Siase and OSGE on the Ca2+ response. (a) CD8 T-cell Ca2+ responses were induced by non-cross-linked anti-CD3 in
young (Y) and old (O) mice, either with or without pretreatment by CP-Siase (left panels) or OSGE (right panels). Top panels: CD8 T cells.
Middle panels: Naive CD8 T cells, i.e. gated for low expression of CD44. Bottom panels: Memory CD8 T cells, i.e. gated for high expression of
CD44. The break in each line shows where stimulatory antibody was added after 20 s of baseline data collection. The panels illustrate one experi-
ment of the eight used in the statistical analysis. (b) The increase in response above baseline for all the experiments conducted. Left panel: CD8
T cells, middle panel: naive CD8 T cells, right panel: memory CD8 T cells. The symbols * and  indicate statistically significant difference with
untreated young or old cells, respectively. **Denotes statistically significant difference between young and old.
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when generated, show an age-dependent decline in lytic
function remains unsettled.28,29 To address the issue,
splenocytes from young and old C57BL/6 mice were cul-
tured with irradiated splenocytes from young CB6F1 mice
to induce the differentiation of H-2d-specific cytotoxic
effectors. CD8 T cells were then purified by negative
selection. The purified cells were either left untreated or
were treated with CP-Siase or OSGE, and then incubated
with 51Cr-labelled P815 cells for 4 hr over a range of
effector: target ratios. Figure 4 (upper panels) shows the
outcome of this effector cell titration in one of the six
experiments conducted. CD8 T cells from both young
and old mice display the highest percent lysis at the
30 : 1 effector : target ratio, with a linear decline in lytic
activity at lower ratios. Figure 4 (lower panel) displays
the percent lysis obtained at the 30 : 1 ratio in each
experiment. Statistical analysis of this data set showed
that, in the absence of enzymatic treatment, CD8 T cells
from young donors were less effective than those from
old donors at lysing target cells (P ¼ 001). Furthermore,
both CP-Siase and OSGE increased the percentage of
target cell lysis by CD8 T cells derived from young (CP-
Siase: P ¼ 0002; OSGE: P ¼ 001) and old (CP-Siase:
P ¼ 00005; OSGE: P ¼ 0002) mice.
Figure 2. CP-Siase and OSGE enhance the expression of early acti-
vation markers on CD8 T cells of young and old mice. T cells from
young and old mice were either left untreated or treated with CP-
Siase or OSGE, and then stimulated with non-cross-linked anti-CD3
and anti-CD28. Gated CD8 T cells were examined for CD69 expres-
sion after 6 hr, and for CD25 expression after 24 hr of stimulation.
(a) Histograms of CD69 (upper panels) and CD25 (lower panels)
expression in one young (Y) and one old (O) mouse. Mean fluores-
cence intensity (MFI) of the traces are shown at the top right corner
of each panel. (b) Bar graphs of the percentage of CD8 T cells
expressing CD69 (left panel) and CD25 (right panel). The bars rep-
resent the mean ± SEM of six young and six old mice for CD69,
and five young and five old mice for CD25. The symbols * and 
indicate statistically significant difference with untreated young or
old, respectively. Unstimulated CD8 T cells (whether untreated or































Figure 3. CP-Siase and OSGE increase the secretion of IL-2 and
IFN-c by CD8 T cells of young and old mice. CD8 T cells from
young (light bars) and old (dark bars) mice were either left
untreated or treated with CP-Siase or OSGE, and then stimulated
with non-cross-linked anti-CD3 and anti-CD28 for 6 hr. The collec-
ted supernatants were analysed for IL-2 (left panel), and IFN-c (right
panel) content by ELISA. The bars represent the mean ± SEM of five
young and five old mice for IL-2, and six young and six old mice
for IFN-c. The symbols * and  indicate statistically significant dif-
ference with untreated young or old, respectively. **Denotes statisti-
cally significant difference between young and old. IL-2 and IFN-c
were undetectable in supernatants from unstimulated CD8 T cells
(whether untreated or enzyme-treated) of either age group.
Figure 4. CP-Siase and OSGE pretreatment enhance CD8 T cell-
mediated cytotoxicity. Young and old CD8 T cells purified after
incubation with irradiated stimulator cells were either left untreated
or were treated with CP-Siase or OSGE. They were then incubated
with 5000 51Cr-labelled P815 target cells in triplicate at effector to
target ratios of 30 : 1, 10 : 1, 3 : 1, and 1 : 1 for 4 hr. The upper
panels show the corrected percent lysis of target cells by CD8 T cells
from one young (upper left) and one old (upper right) mouse at all
the examined effector : target ratios. The lower panel shows the cor-
rected percent lysis of target cells at the 30 : 1 ratio for all the
experiments conducted. The symbols * and  indicate statistically
significant difference with untreated young or old, respectively.
**Denotes statistically significant difference between young and old.
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CP-Siase and OSGE enhance anti-CD3/CD28- and
IL-2-induced granzyme B expression in CD8 T cells
Granzyme B is a caspase-like serine protease that is
released by cytotoxic lymphocytes during their interaction
with target cells, and might contribute to targeted cell
death through inducing DNA fragmentation or BH3 inter-
acting domain death agonist (BID)-mediated release of
cytochrome C from mitochondria.30 To examine the
effects of CP-Siase and OSGE on granzyme B expression,
splenic T cells (either untreated or pretreated with
CP-Siase or OSGE) were stimulated with cross-linked
anti-CD3 and anti-CD28 for 6 hr. The cells were then
stained for surface CD8, and for intracellular granzyme
B. Up-regulation of CD44 during the 6 hr activation per-
iod precluded the use of this marker to distinguish
between naive and memory CD8 T cells. Figure 5(a)
shows the outcome of one of four experiments conducted.
In the absence of enzyme treatment, CD8 T cells from old
donors had significantly higher expression of granzyme B
than those from the young (P ¼ 001). Pre-treatment with
either CP-Siase or OSGE led to an increase in activation-
induced granzyme B expression in CD8 T cells of both the
young (CP-Siase: P ¼ 00009; OSGE: P ¼ 0002) and old
(CP-Siase: P ¼0007; OSGE: 003) age groups (Fig. 5a,
upper panels, and Fig. 5b, left panel).
Concurrently, splenic T cells from the same mice
(either untreated or pretreated with CP-Siase or OSGE)
were incubated with IL-2 for 72 hr in the absence of anti-
CD3/CD28 stimulation. They were then labelled for sur-
face CD8, and for intracellular granzyme B. Once again,
in the absence of enzyme treatment, CD8 T cells from old
donors had a more pronounced expression of granzyme
B than their young counterparts (P ¼ 00009). Further-
more, pretreatment with the enzymes enhanced the IL-2-
induced expression of granzyme B in CD8 T cells of both
young (CP-Siase: P ¼ 00009; OSGE: P ¼ 0008) and old
(CP-Siase: P ¼ 002; OSGE: P ¼ 002) animals (Fig. 5a,
lower panels, and Fig. 5b, right panel).
Discussion
Our previous work has shown that pretreatment of CD4
T cells with either CP-Siase or OSGE can enhance TCR-
mediated CD4 T-cell function at multiple levels.11,19,20
The present study demonstrates that pretreatment of CD8
T cells with either of these enzymes enhances the CD3-
mediated Ca2+ response in CD8 T cells and their subsets;
augments the induced expression of CD69 and CD25;
heightens the CD3/CD28-mediated production of IL-2
and IFN-c; enhances CD3/CD28- and IL-2-induced gran-
zyme B expression; and increases CD8 T-cell cytolytic
activity in vitro in both young and old mice. These find-
ings indicate that the enhancing effects of CP-Siase and
OSGE on T-cell function are not limited to CD4 T cells,
but pertain to CD8 T cells as well.
Our laboratory31 and others32 have previously shown
an age effect on the CD3-mediated Ca2+ response in
CD8 T cells and their memory subset, and that memory
CD8 T cells mount a significantly lower Ca2+ response
than their naive counterparts. The present study confirms
these findings. Unlike CD4 T cells11,19 CD8 T cells
showed no significant ageing effect on the induced
expression of either CD69 or CD25. As for cytokine pro-
duction, measurement of cytokine content in activated
CD8 T-cell supernatants showed a significant age effect
on IFN-c production, in concordance with previous find-
ings,33 but not for IL-2. The higher production of IFN-c
is plausibly caused by the higher proportion of memory
T cells in the CD8 pools of older donors. Furthermore,
in agreement with previous reports34 intracellular stain-
ing documented a significant increase in the percentage
of IL-2- and IFN-c-producing CD8 T cells with age (data
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Figure 5. CP-Siase and OSGE pretreatment increase CD3/CD28-
and IL-2-induced granzyme B expression in CD8 T cells. (a) T cells
from young (Y) and old (O) mice were either left untreated or were
treated with CP-Siase or OSGE, and then stimulated with cross-
linked anti-CD3 and anti-CD28 for 6 hr (upper panels), or incuba-
ted with 100 IU of recombinant IL-2 for 72 hr (lower panels). For
each set of samples, gated CD8 T cells were examined for granzyme
B expression at the end of the incubation period. The graphs illus-
trate one experiment of the four used in the statistical analysis. The
far left trace in each panel is the isotype control. (b) Mean fluores-
cence intensities (MFI) of granzyme B expression for all experiments
conducted. The symbols * and  indicate statistically significant dif-
ference with untreated young or old, respectively. **Denotes statisti-
cally significant difference between young and old.
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were enhanced by enzymatic treatment in both age
groups.
The CD3-mediated Ca2+ response is an early activation
event, which precedes the development of a mature syn-
apse and is initiated within seconds of the formation of
TCR microclusters.35 In contrast, the expression of early
activation markers and production of cytokines follow the
generation of a stable synapse. Furthermore, although the
expression of CD69 and CD25 depend on the activity of
a limited number of transcription factors,36,37 the produc-
tion of cytokines requires sustained TCR engagement and
the integrated effect of numerous waves of gene acti-
vation.38 The enhancement of all these functions by
CP-Siase and OSGE suggests that, in CD8 T cells, cell
surface glycoproteins might act to inhibit both early and
late aspects of the activation process.
Ca2+ influx, expression of early activation markers, and
cytokine production are shared manifestations of activa-
tion between CD4 and CD8 T cells, whereas the genera-
tion of cytotoxic effectors and expression of granzyme B
are specialized characteristics of the CD8 T-cell subset.
Cytotoxic T lymphocytes (CTL) use two distinct cytolytic
pathways in vitro: the Fas ligand/Fas pathway, and the
granule exocytosis pathway.39 In the latter, granzyme B
entry into the target cell will cause caspase activation and
apoptosis either directly or through mitochondrial
damage.30 The enhancement of CD8 T-cell mediated
cytotoxicity in vitro, and the increase in CD3/CD28- and
IL-2-induced granzyme B expression in CD8 T cells after
treatment with either CP-Siase or OSGE shows that the
two enzymes augment specialized CD8 T-cell functions as
well as those aspects of activation that are shared by CD4
and CD8 T cells.
The present study gives further credence to a model5 in
which T cells from young and old mice contain specific
polysaccharide moieties on their surface that can hinder
maximal T-cell signalling and function, and where ageing
leads to further changes in the levels or functional effects
of these glycoproteins. In this model, CP-Siase- and
OSGE-mediated cleavage of these determinants would
leave T cells from young and old donors with similar pat-
terns of surface glycosylation, and thus with comparable
functional ability, as now evidenced by our data on both
CD411,19,20 and CD8 T cells.
The increase with age in the expression of glycan-
dependent CD43 determinants on anergic CD4 T cells,
together with the age-related decline in the exclusion of
CD43 from the immunological synapse, had suggested
that cleavage of CD43 by CP-Siase and OSGE might
underlie the enhancing effects of the enzymes on T-cell
function.11,19,20 Nonetheless, our recent work on young
CD43 knockout mice proves that the enhancing effects of
CP-Siase and OSGE on CD4 and CD8 T-cell function are
even present in CD43-deficient mice.40 This suggests that,
at least in young animals, CP-Siase- and OSGE-sensitive
molecules other than CD43 contribute to the inhibition
of T-cell function.
Studies of CD8 ligand binding have shown that mature
CD8 T cells bind less avidly to ligands than their thymic
precursors. This is in part caused by differential sialyla-
tion of CD8b by ST3Gal-I sialyltransferase over the course
of development.16,17 Some might therefore argue that the
effects examined in this work could result from the clea-
vage of CD8 itself by CP-Siase or OSGE. This is quite
unlikely because the enzymes have similar effects on
CD4 T-cell function, and in contrast to CP-Siase and
OSGE, the sialidase used in an earlier study does not
improve the Ca2+ response in mature CD8 T cells.17
Lastly, the functional responses examined in the present
report are triggered by ligation of CD3, with or without
CD28, and do not require the binding of CD8 to MHC
determinants.
Additional work will be required to identify the specific
T-cell surface glycoproteins responsible for hindering
optimal T-cell signalling, and to determine which ones
display a susceptibility to enzymatic digestion that paral-
lels the enzymes’ ability to enhance T-cell function. New
data on these points might help us develop novel approa-
ches to the restoration of immune function in the elderly.
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